<DOC>
	<DOCNO>NCT01077570</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study , normal clinical practice condition , investigate clinical safety effectiveness Chinese patient type 2 diabetes never receive anti-diabetic treatment .</brief_summary>
	<brief_title>An Observational Study Investigating Safety Effectiveness Repaglinide Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<criteria>HbA1c 6.5 % , antidiabetes treatment accept enter study Subjects receive antidiabetic treatment previously Known suspect allergy trial product ( ) relate product . Subjects previously enrol study . Females childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>